{
    "nctId": "NCT04688086",
    "briefTitle": "A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers",
    "officialTitle": "A Prospective Study to Evaluate the Effectiveness of Thermalytix (AI-based Thermographic Solution Developed by Niramai) for Breast Cancer Screening as Compared to Standard Screening Modalities for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Early Detection of Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 687,
    "primaryOutcomeMeasure": "Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value of Thermalytix",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female subjects equal to and above 18 years\n2. Subjects who are willing to give written informed consent for study participation\n3. Subjects who are ready to comply with the study related visits and procedures\n\nExclusion Criteria:\n\n1. Subjects who are pregnant\n2. Subjects who are lactating\n3. Subjects who have undergone either lumpectomy or mastectomy\n4. Subjects who have undergone chemotherapy in the last 2 weeks at the time of study enrollment\n5. Any active illness, psychological and/or pathological condition that would interfere with study participation in the opinion of the Investigator",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}